• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA IDL SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA IDL SET Back to Search Results
Model Number 12320
Device Problems Gas/Air Leak (2946); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Anemia (1706); Tachycardia (2095)
Event Date 03/11/2020
Event Type  Injury  
Manufacturer Narrative
Investigation: the customer performed a custom prime for this procedure and the leurs were tight.The customer also reported that the patients mother was concerned the patient received air, but it has not been confirmed if that did occur.Investigation is in process.A follow-up report will be provided.
 
Event Description
The customer reported that during a continuous mononuclear cell (cmnc) collection, there were air bubbles seen past the point of detection by the machine.In the blood warmer tubing line, microbubbles that formed into a big bubble were noted and the procedure was stopped.The patient remained alert and awake; no hypoxemia.An ecg was ordered.A cbc was drawn, which showed severe anemia and worsening thrombocytopenia.The patient received packed red blood cells because the hemoglobin dropped from 8 to 5.5.Saline was provided to the patient because the patient had gotten tachycardic and hypotensive.The patient was admitted for monitoring and for a 2nd collection and is continuing oncology road map or treatment plan.The disposable set is not available for return because it was discarded by the customer.
 
Manufacturer Narrative
This report is being filed to provide additional information in h.6 and h.10.Investigation: according to therapeutic apheresis: a physician's handbook, adverse events occur during therapeutic procedures with a frequency of 4.8%.Some of the most common reactions include fever, urticaria, hypocalcemic symptoms, pruritus, dyspnea, tachycardia, and mild hypotension.Root cause: based on information provided in the clinical findings, the root cause of the air bubbles noted in blood warmer tubing are a result of outgassing.The operator noted that no hypoxemia was observed in the patient, asserting an air embolism did not occur.Given the patient's type of symptoms, she was likely experiencing typical reactions related to collection procedures and/or her medical condition.
 
Manufacturer Narrative
This report is being filed to provide additional information in h.6 and h.10.Investigation: a disposable history search for lot 1912093230 found no other reports of a similar failure.A review of the device history record (dhr) for this unit showed no irregularities during manufacturing that were relevant to this issue.Analysis of the run data file was not performed; however, the operator confirmed there were no rlad alarms during the procedure which indicate the air bubbles were isolated to the blood warmer tubing and were likely a result of outgassing.This phenomenon, called "outgassing," occurs because gasses are more soluble in low temperature liquids than in liquids at higher temperatures.If air is available to dissolve in a fluid at a low storage temperature and approaches its equilibrium solubility at that temperature, the air will come out of the solution when the fluid is warmed because its solubility is exceeded at the higher temperature.If replacement fluids are not allowed to warm to room temperature prior to procedures, and if the blood returned to the patient is warmed using a blood warmer, air bubbles may form during warming.They are usually described as chains of very small bubbles or foam, which tend to rise toward the top of the tubing and may coalesce to form larger bubbles.Outgassing is sometimes also seen when blood or replacement fluids are re-warmed by the blood warmer in procedures.Correction: terumo bct clinical specialist provided the operator with outgassing information and the blood warmer ifu for tubing connections.Investigation is in process.A follow up report will be provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPECTRA OPTIA
Type of Device
SPECTRA OPTIA IDL SET
Manufacturer (Section D)
TERUMO BCT
lakewood CO 80215
MDR Report Key10121134
MDR Text Key196112807
Report Number1722028-2020-00272
Device Sequence Number1
Product Code LKN
UDI-Device Identifier05020583123205
UDI-Public05020583123205
Combination Product (y/n)N
PMA/PMN Number
K183081
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup,Followup
Report Date 06/04/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/04/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/01/2021
Device Model Number12320
Device Catalogue Number12320
Device Lot Number1912093230
Was Device Available for Evaluation? No
Was the Report Sent to FDA? Yes
Date Manufacturer Received09/28/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
BLOOD WARMER - ASTOTHERM
Patient Outcome(s) Other; Required Intervention;
Patient Age18 MO
Patient Weight10
-
-